MedTrace Logo

Electronic Brachytherapy for the Treatment of NMSC

NCT01016899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 187

Last updated 2022-12-13

No results posted yet for this study

Summary

The objective of this study is to record recurrence in patients treated for nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent Electronic Brachytherapy System. Additional objectives include evaluate the appearance of the treated area in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic Brachytherapy System and record the occurrence of radiation therapy related skin changes in patients treated for nonmelanoma skin cancer.

Conditions

Interventions

RADIATION

electronic brachytherapy

Post market observational study recording data form patients with skin cancer treated with electronic brachytherapy. Treatment is standard of care, and can vary in dose and fractionation schedule from patient to patient depending on radiation oncologist's judgement for best treatment for the patient.

Sponsors & Collaborators

  • Xoft, Inc.

    lead INDUSTRY

Principal Investigators

  • Ajay Bhatnagar, MD, MBA · Cancer Treatment Services-AZ

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01016899 on ClinicalTrials.gov